Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines

Molecular and Cellular Proteomics

Volumn 8, Issue 12, 2009, Pages 2746-2758

  Planque, Chris ^a,b   Kulasingam, Vathany ^a,b   Smith, Chris R ^c   Reckamp, Karen ^d   Goodglick, Lee ^e   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; CONNECTIVE TISSUE GROWTH FACTOR; CREATINE KINASE BB; FOLLISTATIN; KALLIKREIN; NERVE CELL ADHESION MOLECULE; OSTEOPROTEGERIN; PENTRAXIN 3; PROGASTRIN RELEASING PEPTIDE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LIQUID CHROMATOGRAPHY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE SPECIFICITY;

ADAM PROTEINS; ANIMALS; CELL LINE, TUMOR; CHO CELLS; CHROMATOGRAPHY, LIQUID; CRICETINAE; CRICETULUS; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SPACE; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 75149133225     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900134-MCP200     Document Type: Article

References (69)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M. J. (2007) Cancer statistics. CA Cancer J. Clin. 57, 43-66
2. Brybom, M., Adner, M., and Cardeil, L. O. (2005) Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir. Res. 6, 118
3. Casado, B., Pannell, L. K., Iadarola, P., and Baraniuk, J. N. (2005) Identification of human nasal mucous proteins using proteomics. Proteomics 5, 2949-2959
4. Lindahl, M., Irander, K., Tagesson, C, and Ståhlbom, B. (2004) Nasal lavage fluid and proteomics as means to identify the effects of the irritating epoxy chemical dimethylbenzylamine. Biomarkers 9, 56-70
5. Sabounchi-Schütt, F., Aström, J., Hellman, U., Eklund, A., and Grunewald, J. (2003) Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach. Eur. Respir. J. 21, 414-420
6. Wu, J., Kobayashi, M., Sousa, E. A., Liu, W., Cai, J., Goldman, S. J., Domer, A. J., Projan, S. J., Kavuru, M. S., Qiu, Y., and Thomassen, M. J. (2005) Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol. Cell. Proteomics 4, 1251-1264
7. Xie, H., Rhodus, N. L., Griffin, R. J., Carlis, J. V., and Griffin, T. J. (2005) A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol. Cell. Proteomics 4, 1826-1830
8. Hu, S., Xie, Y., Ramachandran, P., Ogorzalek Loo, R. R., Li, Y., Loo, J. A., and Wong, D. T. (2005) Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5, 1714-1728
9. Nicholas, B., Skipp, P., Mould, R., Rennard, S., Davies, D. E., O'Connor, C. D., and Djukanoviae, R. (2006) Shotgun proteomic analysis of human-induced sputum. Proteomics 6, 4390-4401
10. Casado, B., Iadarola, P., Pannell, L K., Luisetti, M., Corsico, A, Ansaldo, E., Ferrarotti, I., Boschetto. P., and Baraniuk, J. N. (2007) Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J. Proteome Res. 6, 4615-4623
11. Tyan, Y. C., Wu, H. Y., Lai, W. W., Su, W. C., and Liao, P. C. (2005) Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J. Proteome Res. 4, 1274-1286
12. Jacobs, J. M., Adkins, J. N., Qian, W. J., Liu, T., Shen, Y., Camp, D. G., 2nd, and Smith, R. D. (2005) Utilizing human blood plasma for proteomic biomarker discovery. J. Proteome Res. 4, 1073-1085
13. Qian, W. J., Jacobs, J. M., Liu, T., Camp, D. G., 2nd, and Smith, R. D. (2006) Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics 5, 1727-1744
14. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6, 1997-2011
15. Sardana, G., Jung, K., Stephan, C., and Diamandis, E. P. (2008) Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J. Proteome Res. 7, 3329-3338
16. Tachibana, I., Mori, M., Tanio, Y., Hosoe, S., Sakuma, T., Osaki, T., Ueno, K., Kumagai, T., Kijima, T., and Kishimoto, T. (1996) A 100-kDa protein tyrosine phosphorylation is concurrent with beta 1 integrin-mediated morphological differentiation in neuroblastoma and small cell lung cancer cells. Exp. Cell Res. 227, 230-239
17. Lou, X., Xiao, T., Zhao, K., Wang, H., Zheng. H., Lin, D., Lu. Y., Gao, Y., Cheng, S., Liu, S., and Xu, N. (2007) Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer. J. Proteome Res. 6, 1083-1092
18. Xiao, T., Ying, W., Li, L., Hu, Z., Ma, Y., Jiao, L., Ma, J., Cai, Y., Lin, D., Guo, S., Han, N., Di, X., Li, M., Zhang, D., Su, K., Yuan, J., Zheng, H., Gao, M., He, J., Shi, S., Li, W., Xu, N., Zhang, H., Liu. Y., Zhang, K., Gao, Y., Qian, X., and Cheng, S. (2005) An approach to studying lung cancer-related proteins in human blood. Mol. Cell. Proteomics 4, 1480-1486
19. Borgoño, C. A., Michael, I. P., Shaw, J. L., Luo, L. Y., Ghosh, M. C. Soosaipillai, A., Grass, L., Katsaros, D., and Diamandis, E. P. (2007) Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J. Biol. Chem. 282, 2405-2422
20. Diamandis, E. P., Borgorio, C. A., Scorilas, A., Harbeck, N., Dorn, J., and Schmitt, M. (2004) Human kallikrein 11 : an indicator of favorable prognosis in ovarian cancer patients. Clin. Biochem. 37, 823-829
21. Shaw, J. L., and Diamandis, E. P. (2007) Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432
22. Kersey, P. J., Duarte, J., Williams, A., Karavidopoulou, Y., Birney, E., and Apweiler, R. (2004) The International Protein Index: an integrated database for proteomics experiments. Proteomics 4, 1985-1988
23. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
24. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
25. Huang, L. J., Chen, S. X., Huang, Y., Luo, W. J., Jiang, H. H., Hu, Q. H., Zhang, P. F., and Yi, H. (2006) Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54, 87-94
26. Tian, T., Hao, J., Xu, A., Hao, J., Luo, C, Liu, C, Huang, L., Xiao, X., and He, D. (2007) Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci. 98, 1265-1274
27. Salgia, R., Harpole, D., Herndon, J. E., 2nd, Pisick, E., Elias, A., and Skarin, A. T. (2001) Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res. 21, 1241-1246
28. Shoji, F., Yoshino, I., Yano, T., Kometani, T., Ohba, T., Kouso, H., Takenaka, T., Miura, N., Okazaki, H., and Maehara, Y. (2007) Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas. Cancer 110, 2793-2798
29. Nisman, B., Heching, N., Biran, H., Barak, V., and Peretz, T. (2006) The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Tumour Biol. 27, 8-16
30. Tötsch, M., Müller, L. C, Hittmair, A., Ofner, D., Gibbs, A. R., and Schmid, K. W. (1992) Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung. Hum. Pathol. 23, 312-316
31. Takada, M., Kusunoki, Y., Masuda, N., Matui, K., Yana, T., Ushijima, S., Iida, K., Tamura, K., Komiya, T., Kawase, I., Kikui, N., Morino, H., and Fukuoka, M. (1996) Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer, comparative evaluation with neuron-specific enolase. Br. J. Cancer 73, 1227-1232
32. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C, Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A. 98, 13790-13795
33. Planque, C., Li, L., Zheng, Y., Soosaipillai, A., Reckamp, K., Chia, D., Diamandis, E. P., and Goodglick, L. (2008) A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin. Cancer Res. 14, 1355-1362
34. Planque, C., Blechet, C, Ayadi-Kaddour, A., Heuzé-Vourc'h, N., Dumont, P., Guyétant, S., Diamandis, E. P., El Mezni, F., and Courty, Y. (2008) Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung. Biol. Chem. 389, 781-786
35. Lynch, D. F., Jr., Hassen, W., Clements, M. A., Schellhammer, P. F., and Wright, G. L., Jr. (1997) Serum levels of endothelial and neural cell adhesion molecules in prostate cancer. Prostate 32, 214-220
36. Jaques, G., Auerbach, B., Pritsch, M., Wolf, M., Madry, N., and Havemann, K. (1993) Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer. Cancer 72, 418-425
37. Ledermann, J. A., Pasini, F., Olabiran, Y., and Pelosi, G. (1994) Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration. Int. J. Cancer Suppl. 8, 49-52
38. Magi, B., Bargagli, E., Bini, L., and Rottoli, P. (2006) Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6, 6354-6369
39. Issaq, H. J. (2001) The role of separation science in proteomics research. Electrophoresis 22, 3629-3638
40. Cho, C. K., Shan, S. J., Winsor, E. J., and Diamandis, E. P. (2007) Proteomics analysis of human amniotic fluid. Mol. Cell. Proteomics 6, 1406-1415
41. Shaw, J. L., Smith, C R., and Diamandis, E. P. (2007) Proteomic analysis of human cervico-vaginal fluid. J. Proteome Res. 6, 2859-2865
42. Martin, D. B., Gifford, D. R., Wright, M. E., Keller, A., Yi, E., Goodlett, D. R., Aebersold, R., and Nelson, P. S. (2004) Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res. 64, 347-355
43. Li, C., Hong, Y., Tan, Y. X., Zhou, H., Ai, J. H., Li, S. J., Zhang, L., Xia, Q. C., Wu, J. R., Wang, H. Y., and Zeng, R. (2004) Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol. Cell. Proteomics 3, 399-409
44. Yocum, A. K., Busch, C M., Felix, C A., and Blair, I. A. (2006) Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. J. Proteome Res. 5, 2743-2753
45. Kapp, E. A., Schütz, F., Connolly, L M., Chakel, J. A., Meza, J. E., Miller, C. A., Fenyo, D., Eng, J. K., Adkins, J. N., Omenn, G. S., and Simpson, R. J. (2005) An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 5, 3475-3490
46. Domon, B., and Aebersold, R. (2006) Challenges and opportunities in proteomics data analysis. Mol. Cell. Proteomics 5, 1921-1926
47. Kagohashi, K., Satoh, H., Kurishima, K., Kadono, K., Ishikawa, H., Ohtsuka, M., and Sekizawa, K. (2008) Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases. Lung 186, 323-326
48. Vassilakopoulos, T., Troupis, T., Sotiropoulou, C, Zacharatos, P., Katsaou-nou, P., Parthenis, D., Noussia, O., Troupis, G., Papiris, S., Kittas, C., Roussos, C., Zakynthinos, S., and Gorgoulis, V. (2001) Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 32, 137-144
49. Schneider, J., Velcovsky, H. G., Morr, H., Katz, N., Neu, K., and Eigenbrodt, E. (2000) Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer. Anticancer Res. 20, 5053-5058
50. Liotta. L A., Ferrari, M., and Petricoin, E. (2003) Clinical proteomics: written in blood. Nature 425, 905
51. Santiago-Josefat, B., Esselens, C., Bech-Serra, J. J., and Arribas, J. (2007) Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. J. Biol. Chem. 282, 8325-8331
52. McGowan, P. M., Ryan, B. M., Hill, A. D., McDermott, E., O'Higgins, N., and Duffy, M. J. (2007) ADAM-17 expression in breast cancer correlates with variables of tumor progression. Clin. Cancer Res. 13, 2335-2343
53. McGowan, P. M., McKiernan, E., Bolster, F., Ryan, B. M., Hill, A. D., McDermott, E. W., Evoy, D., O'Higgins, N., Crown, J., and Duffy, M. J. (2008) ADAM-17 predicts adverse outcome in patients with breast cancer. Ann. Oncol. 19, 1075-1081
54. Zhou, B. B., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., Yang, G., Li, Y., Yao, W., Vaddi, K., Gazdar, A. F., Friedman, S. M., Jablons, D. M., Newton, R. C., Fridman, J. S., Minna, J. D., and Scherle, P. A. (2006) Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 10, 39-50
55. Breviario, F., d'Aniello, E. M., Golay, J., Peri, G., Bottazzi, B., Bairoch, A., Saccone, S., Marzella, R., Predazzi, V., Rocchi, M., Delia VaIIe, G., Dejana, E., Mantovani, A., and Introna, M. (1992) Interieukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J. Biol. Chem. 267, 22190-22197
56. He, X., Han, B., and Liu, M. (2007) Long pentraxin 3 in pulmonary infection and acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L1039-L1049
57. Thomas, T. Z., Wang, H., Niclasen, P., O'Bryan, M. K., Evans, L W., Groome, N. P., Pedersen, J., and Risbridger, G. P. (1997) Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer. J. Clin. Endocrinol. Metab. 82, 3851-3858
58. McPherson, S. J., Mellor, S. L., Wang, H., Evans, L. W., Groome, N. P., and Risbridger, G. P. (1999) Expression of activin A and follistatin core proteins by human prostate tumor cell lines. Endocrinology 140, 5303-5309
59. Nakagawa, H., Liyanarachchi, S., Davuluri, R. V., Auer, H., Martin, E. W., Jr., de la Chapelle, A., and Frankel, W. L (2004) Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23, 7366-7377
60. Di Simone, N., Crowley, W. F., Jr., Wang, Q. F., Sluss, P. M., and Schneyer, A. L. (1996) Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137, 486-494
61. Ogino, H., Yano, S., Kakiuchi, S., Muguruma, H., Ikuta, K., Hanibuchi, M., Uehara, H., Tsuchida, K., Sugino, H., and Sone, S. (2008) Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin. Cancer Res. 14, 660-667
62. Tomita, Y., Yang, X., Ishida, Y., Nemoto-Sasaki, Y., Kondo, T., Oda, M., Watanabe, G., Chaldakov, G. N., Fujii, C., and Mukaida, N. (2004) Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55. Int. J. Cancer 112, 927-933
63. Lipton, A., Ali, S. M., Leitzel, K., Chinchilli, V., Witters, L., Engle, L., Hollo-way, D., Bekker, P., and Dunstan, C. R. (2002) Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res. 8, 2306-2310
64. Mizutani, Y., Matsubara, H., Yamamoto, K., Nan Li, Y., Mikami, K., Okihara, K., Kawauchi, A., Bonavida, B., and Miki, T. (2004) Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. Cancer 101, 1794-1802
65. Nikliñski, J., Furman, M., Palynyczko, Z., Laudañski, J., and Bulatowicz, J. (1991) Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung. Neoplasma 38, 645-651
66. Nikliñski, J., Furman, M., Laudañski, J., Palynyczko, Z., and WeIk, M. (1991) Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung. Neoplasma 38, 129-135
67. Chen, Y., Zhang, H., Xu, A., Li, N., Liu, J., Liu, C., Lv, D., Wu, S., Huang, L., Yang, S., He, D., and Xiao, X. (2006) Elevation of serum I-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer 54, 95-102
68. Sun, T., Gao, Y., Tan, W., Ma, S., Zhang, X., Wang, Y., Zhang, Q., Guo, Y., Zhao, D., Zeng, C, and Lin, D. (2006) Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression. Clin. Cancer Res. 12, 7009-7017
69. Kim, J. H., Bogner, P. N., Baek, S. H., Ramnath, N., Liang, P., Kim, H. R., Andrews, C., and Park, Y. M. (2008) Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target. Clin. Cancer Res. 14, 2326-2333